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Summary Objectives: The aim of this study is to present a method to provide accu-
rate estimates of inﬂuenza-associated pneumonia and inﬂuenza (P&I) hospitalizations
and costs for use in tracking the continuing burden of inﬂuenza.
Methods: We estimated inﬂuenza-associated P&I hospitalizations among the U.S.
elderly population for six inﬂuenza seasons, 1990—91 through 1995—96, by apply-
ing a Poisson regression model to national inﬂuenza virus surveillance information
and Medicare administrative data. This model is similar to that recently published
by the U.S. National Centers for Disease Control and Prevention (CDC) to estimate
inﬂuenza-related mortality.
Results: During the six years of the study, 318,666 (9.8%) of P&I hospitalizations
were estimated to be associated with inﬂuenza: range = 25,819 to 70,068 per year;
average annual cost = $372.3 million. Inﬂuenza A(H3N2) was associated with 73.9% of
inﬂuenza-related P&I hospitalizations; inﬂuenza B with 21.3% and inﬂuenza A(H1N1)
with 4.8%.
Conclusions: Our estimates were consistent with the estimates of inﬂuenza-asso-
ciated P&I mortality reported by CDC. Thus, we suggest that estimates of inﬂuenza-
associated morbidity and costs based on virus surveillance and administrative data
may be used for monitoring the impact of inﬂuenza and of intervention strategies.
© 2004 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
Introduction
Recently, Thompson et al.1 used Poisson regression
models that included national inﬂuenza and respi-
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ratory syncytial virus (RSV) laboratory surveillance
data to estimate inﬂuenza- and RSV-associated
deaths in the United States for the inﬂuenza sea-
sons 1975—1976 through 1998—1999. These models
estimated the virus-speciﬁc number of deaths due
to inﬂuenza A(H1N1), inﬂuenza A(H3N2) and in-
ﬂuenza B, as well as RSV, for deaths with the under-
lying cause listed as pneumonia or inﬂuenza (P&I)
(ICD-9 codes 480—487), respiratory and circulatory
diseases (ICD-9 codes 390—519 and ICD-10 codes
I00—I99, J00—J99), and all-causes. The United
1201-9712/$30.00 © 2004 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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States’ National Centers for Disease Control and
Prevention (CDC) plans to use these new models to
estimate the mortality impact of these viruses in
the future.
As important as monitoring inﬂuenza-associated
mortality is the monitoring of inﬂuenza-related
morbidity, especially hospitalizations. This is par-
ticularly true because between 1980 and 1994,
hospitalizations in the United States for lower res-
piratory tract infections among persons of all ages
increased at an annual rate of 2.2%2, and the rate
of P&I hospitalization among the American elderly
increased by 51% between 1986 and 1999; from
15.5/1,000 to 23.4/1,000 among Medicare bene-
ﬁciaries greater than 65 years of age (Center for
Medicare and Medicaid Services, unpublished data).
The National Centers for Infectious Diseases,
CDC has kindly provided us with the same national
inﬂuenza virus surveillance data for the inﬂuenza
years 1990—91 through 1995—1996, as was used in
their study of P&I mortality.1 We have used these
data in combination with Medicare administrative
data in similar regression models to estimate the
P&I hospitalizations and the cost of these hospital-
izations among the group with the highest rates of
inﬂuenza hospitalizations and death, namely, the
elderly.
Material and methods
Inﬂuenza virus laboratory surveillance
information
The methods of collection of these data are de-
scribed in detail by Thompson et al.1. Brieﬂy
stated, from October through mid-May approxi-
mately 70 World Health Organization Collaborating
virology laboratories in the United States submit
weekly counts of respiratory specimens tested for
inﬂuenza virus, as well as the positive inﬂuenza
isolates by virus type and subtype.
Hospitalization and demographic
information
The Medicare program’s Medicare Provider and
Analysis (MedPAR) ﬁles and Denominator ﬁles for
each year 1990 through 1996 were used. The Med-
PAR ﬁle contains one record for each hospitaliza-
tion of a Medicare beneﬁciary. We used what is
called the 20% MedPAR ﬁle which contains all hos-
pitalizations for a random probability sample of
20% of Medicare beneﬁciaries. For each hospital-
ization we used the beneﬁciary’s unique Health
Insurance Claim (HIC), his/her age, the date of ad-
mission, and the principal diagnosis in our analysis.
Hospitalizations were considered to be due to P&I
if the ICD-9 code for the principal diagnosis was
480—487. The unique HIC allowed us to exclude
all hospitalizations that occurred within 15 days
of discharge of a prior hospitalization for P&I. All
estimates from the 20% ﬁle were multiplied by ﬁve
to give estimates for the total Medicare popula-
tion. The annual 100% Medicare Denominator ﬁles
contain basic demographic (HIC, date of birth, gen-
der, state, county and zip code of residence, and
date of death) and enrollment information (the
speciﬁc months of enrollment in Medicare, as well
as in Medicare managed care plans) on each per-
son enrolled in the Medicare program in that year.
The Denominator ﬁles were used to calculate the
weekly Medicare population 65 years of age and
older who resided in the 50 states and the District
of Columbia.
Since 1982, Medicare beneﬁciaries have had the
option of receiving care from providers who are paid
on a fee-for-service (FFS) basis (the so-called tradi-
tional Medicare), or to receive care under the aus-
pices of a Medicare approved managed care plan
(Medicare managed care, or MMC). Almost all MMC
plans are paid on a capitated basis. Thus, these
plans agree to provide services to Medicare beneﬁ-
ciaries for a ﬁxed price, generally 95% of the pre-
vailing FFS costs of care in the area of residence,
adjusted for gender, age and whether or not the
person is also enrolled in a state Medicaid program,
the program in the United States for the medically
needy.3 Managed care plans are mandated by Medi-
care to provide information about hospitalizations
that is similar to that provided by the FFS providers.
However, this is irregularly done. Thus, we followed
the convention of researchers using Medicare ad-
ministrative data of excluding those persons inman-
aged care plans. During the period of this study
between 5.9% and 11.3% of Medicare beneﬁciaries
were enrolled in managed care plans.
Statistical analysis
The Poisson regression model we used was essen-
tially that of Thompson et al.1 substituting hospi-
talizations for deaths as the outcome measure, and
excluding the RSV term. It is reproduced below.
Yt = αt exp{βo + β1[t]+ β2[t2]+ β3
[
sin
(
2πt
52
)]
+ β4
[
cos
2πt
52
]
+ β5[A(H1N1)t]
+ β6(A(H3N2)t]+ β7Bt}
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Yt equals the number of hospitalizations in week
t for persons greater than 65 years of age; α is the
exposure term and is equal to the log of the popula-
tion greater than 65 years of age; β0 represents the
intercept; β1 accounts for the linear time trend; β2
accounts for the non-linear time trend; β3 and β4
account for seasonal changes in hospitalizations; β5
through β7 represent coefﬁcients associated with
the percentage of inﬂuenza specimens testing pos-
itive in a given week; t = the ordinal time in weeks
(1—324).
The model was ﬁtted to the inﬂuenza laboratory
surveillance data and the Medicare data for the
1990—1991 through 1995—1996 seasons. Analyses
were conducted using STATA statistical software,
version 7.0 (Stata Corporation, College Station,
Texas).
Estimates of the cost to Medicare
For each epidemic year, we estimated the aver-
age cost to Medicare for a hospitalization due to
inﬂuenza-associated P&I to be the average cost
of P&I hospitalizations during the months that
CDC reported the number of deaths in the 121
Cities Surveillance System to have exceeded the
epidemic threshold.4 The 121 Cities Surveillance
System has been used for over four decades to re-
port P&I deaths as a percentage of all deaths by
week in 121 U.S. cities. For 1991—92, they were
December through February;5 for 1992—93 they
were March through May;4 for 1993—94, they were
December through February;4 for 1994—95, they
were February through April;6 for 1995—96, they
were December through February.6 In 1990—91, the
epidemic threshold was not reached;7 therefore,
we used the months of January through March. In
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Figure 1 Number of pneumonia and inﬂuenza (P&I) hospitalizations per week (left axis, line) and percent of virus
isolates positive for inﬂuenza (dash, right axis), June 1990—July 96.
addition to the amount paid to the hospitals, Medi-
care pays additional amounts to physicians and
other providers. This amount has been estimated
to equal 20% of the amount paid to the hospital.8
Thus, we added 20% to the amount paid by Medi-
care to the hospital to estimate the total cost to
Medicare of the P&I hospitalizations.
Results
The seasonality of P&I hospitalizations among the
elderly population and the percent positive inﬂu-
enza virus isolations for the six-year period, 1990—
1991 through 1995—1996 are shown in Figure 1.
There is a close similarity between the seasonal
peak periods of the two measures for the six in-
ﬂuenza seasons. The inﬂuenza season with the high-
est weekly peak was 1993—1994, a year when 98.2%
of the inﬂuenza isolates were inﬂuenza A(H3N2).6
During the six-year period 1990—1991 through
1995—1996, there were 3,248,710 P&I hospitaliza-
tions in the elderly Medicare fee-for-service popu-
lation (Table 1). Of these, 318,666 (9.6%) were es-
timated to be due to inﬂuenza. The average annual
number of inﬂuenza-associated hospitalizations
was 53,112 (range = 25,819 to 70,068).
The annual number of P&I hospitalizations asso-
ciated with inﬂuenza A(H3N2) ranged from 5,793 to
69,416 (1.2% to 12.3% of all P&I hospitalizations).
Inﬂuenza B accounted for between 544 and 26,399
P&I hospitalizations (0.1% to 4.8% of all P&I hospital-
izations). Inﬂuenza A(H1N1) was linked to between
108 and 8,453 P&I hospitalizations (<0.1% to 1.51%
of all P&I hospitalizations). Inﬂuenza A(H3N2) was
the cause of 73.9% of inﬂuenza-related P&I hospital-
izations (235,479 of 318,666), followed by inﬂuenza
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B, 21.3% (67,872 hospitalizations), and inﬂuenza
A(H1N1), 4.8% (15,315 hospitalizations).
The greatest number of inﬂuenza-associated
P&I hospitalizations occurred in 1991—1992 and
1993—1994, 68,667 and 70,068, respectively. In
these two years over 12% of all P&I hospitalizations
were due to inﬂuenza. Of these 63,048 (91.8%)
and 69,416 (99.1%), respectively, were associated
with inﬂuenza A(H3N2). 1990—1991 was the year
with the lowest number of inﬂuenza-associated
P&I hospitalizations, 25,819. In that year 86% of
the inﬂuenza isolates were inﬂuenza B,4 and 74.5%
(19,239), of the inﬂuenza-associated P&I hospi-
talizations were related to inﬂuenza B. A graphi-
cal representation of the inﬂuenza-associated P&I
hospitalizations for the six years, as well as the
baseline seasonal trend, is shown in Figure 2.
The estimated annual average cost to the Medi-
care program for hospitalizations due to P&I be-
tween 1990—1991 and 1995—1996 was $372.3 mil-
lion, with a range of $168.3 million to $494.5 mil-
lion (Table 2).
Discussion
There are compelling reasons to use the new
Thompson et al. model and Medicare administrative
data to understand the burden of inﬂuenza in the
elderly. The new model provides information about
the impact of each inﬂuenza virus type and sub-
type and the Medicare data allow population-based
estimates of P&I hospitalizations and costs to be
made. In addition, the model allows the inclusion
of an RSV term, if those data are available, as well
as other explanatory variables.1 For example, if a
surveillance system is established for the recently
described metapneumonia virus9,10 or other lower
respiratory tract viruses, information from that
system could be included. Also, information about
geography, temperature and air pollution could be
added.
The Medicare data are very appealing for making
population-based estimates of P&I hospitalizations
because 98% of elderly Americans are entitled to
Medicare Part A, which covers most of the costs
of hospitalization. Thus, researchers have used
these data to study the impact of inﬂuenza in the
elderly;11 to describe the epidemiology of pneu-
monia in the elderly;12,13 to describe patterns of
care and health outcomes among elderly beneﬁcia-
ries with pneumonia,14—17 including death;18 and
to evaluate the effectiveness of inﬂuenza vaccine
in preventing P&I hospitalizations in beneﬁciaries
with end-stage renal disease.19 The unique contri-
bution of this paper is that it is the ﬁrst attempt to
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Figure 2 Weekly number of ﬂu-related pneumonia and inﬂuenza (P&I) hospitalizations associated with inﬂuenza
(dash) and seasonal trend (line), June 1990—July 1996.
attribute P&I hospitalizations to speciﬁc inﬂuenza
virus types and subtypes. As mentioned in the ma-
terials and methods section, above, we and the re-
searchers cited above who have used the Medicare
data have had to exclude those who are in Medicare
managed care plans, 5.9% to 11.3% of all Medicare
beneﬁciaries in the years of our study, and to limit
the analyses to the fee-for-service population. The
percentage of elderly Medicare beneﬁciaries in
managed care plans peaked at approximately 16%
in 1999, and has been declining since then. Thus,
the Medicare data can provide very useful infor-
mation on the great majority of the elderly U.S.
population. Also, there is no evidence that the
Table 2 Estimated amount (US dollars) reimbursed by the Medicare program for P&I associated hospitalizations,
1990—1991 through 1995—96.
Inﬂuenza
Year
Number of
hospitalizations
due to P&I
Average amount
paid by by Medicare
to hospitals per
hospitalization
Total amount
paid to hospitals
(in millions)
Total amount paid
to physicians and
other providers
(in millions)
Total
amount paid
by Medicare
(in millions)
1990—1991 25,819 $5,433 140.3 28.1 168.3
1991—1992 68,667 $5,635 386.9 77.4 464.3
1992—1993 50,667 $5,899 298.9 59.8 358.7
1993—1994 70,068 $5,881 412.1 82.4 494.5
1994—1995 56,331 $5,928 333.9 66.8 400.7
1995—1996 47,114 $6,147 289.6 57.9 347.5
Total 318,666 1,861.7 372.3 2,234.0
Average 53,112 310.3 62.1 372.3
impact of inﬂuenza is different in this population
than in the fee-for-service population.
As a means of validating our estimates of
inﬂuenza-associated P&I hospitalizations, we esti-
mated the number of deaths among persons hos-
pitalized for P&I in our Medicare population and
compared them to the number of inﬂuenza-related
P&I deaths reported by Thompson et al. for per-
sons greater than 65 years of age (See Table 3 and
Tables 3 and 4 in reference 1). In order to estimate
the number of inﬂuenza-associated P&I deaths in
the Medicare elderly fee-for-service population,
we used estimates of the case/fatality rate for
all fee-for-service P&I hospitalizations available
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to us from the Centers for Medicare and Medicaid
Services (CMS). The rates for 1991 through 1996
ranged from 14.2% to 15.3% (See Table 3). These
rates are consistent with other, published, esti-
mates of 30-day post-admission mortality rates
among elderly Medicare beneﬁciaries hospitalized
for P&I in the United States during the period of
the study.20—22 Assigning all deaths that occur in
the 30-days following admission for P&I to P&I
overestimates the number of deaths due to P&I.
Recently, Mortensen et al. reported on the causes
of death among persons ≥18 years of age hospital-
ized for pneumonia in Pittsburgh, PA, Boston, MA,
and Halifax, Nova Scotia between October 12, 1991
and March 31, 1994.23 Among 114 deaths occurring
within 30 days of hospitalization, 84 (73.7%) were
judged to be pneumonia-related. Unfortunately no
data are presented just for elderly patients.
Applying the annual CMS 30-day post-admission
mortality rates to our P&I hospitalizations in
Table 1, we estimated a total number of deaths
among the Medicare elderly population for the
six years to be 46,288 (Table 3). Using Mortensen
et al.’s correction for causes of death that are
pneumonia-related, our estimated total number
of deaths is 34,114 (Table 3). The former is 27.2%
greater than that calculated from Thompson et al.,
36,399, and the latter is approximately 6% less.
Thus, our estimates of inﬂuenza P&I hospitaliza-
tions appear to be reasonable.
In addition, we compared our estimated rank-
ing of the annual number of inﬂuenza-related P&I
hospitalizations with the ranking of the number of
deaths reported by Thompson et al. using their in-
ﬂuenza only model (Table 2 of reference 1). They
were identical.
Prior estimates of inﬂuenza-related P&I hospi-
talizations among the elderly have been published
using a different model and monthly U.S. National
Hospital Discharge Survey data.24 That model es-
tablishes a baseline for expected P&I hospital-
izations in winter months based on the number
of P&I hospitalizations in winter months in which
inﬂuenza was absent. For the ﬁve inﬂuenza sea-
sons for which data are available for both meth-
ods, 1990—1991 through 1994—1995, our model
estimated 271,552 inﬂuenza-associated P&I hospi-
talizations, versus 427,000 using the other model
(Table 4). The major differences are for the years
1990—1991 and 1992—1993. We do not believe
that the information shown in Figure 1 supports
their results that 1992—1993 was the year with the
greatest number of inﬂuenza-associated P&I hospi-
talizations in the elderly, and a number that is al-
most twice as great in 1992—1993 as in 1991—1992.
It is more reasonable to conclude that the years
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Table 4 Comparison of our estimates of P&I hospitalizations associated with inﬂuenza among persons 65+ years
of age with that of previously published information12.
Inﬂuenza Year Percent of isolates by
virus type or subtypea
Our estimates
from Table 1
Estimates from
Simonsen et al.
Table 1 24
Ratio of our
estimates/
Simonsen et al.
A(H1N1) A(H3N2) B
1990—1991 6 8 86 25,819 81,000 0.319
1991—1992 1 81 18 68,667 68,000 1.010
1992—1993 3 26 71 50,667 133,000 0.381
1993—1994 1 98 1 70,068 93,000 0.753
1994—1995 2 72 26 56,331 52,000 1.083
1995—1996 35 50 15 47,114 N.A. N.A.
Total (1990—91 271,552 427,000 0.636
through 1994—1995)
N.A. = not available.
a References 4 and 6.
1991—1992 and 1993—1994 had a greater number
of inﬂuenza-associated P&I hospitalizations than
1992—1993, which was found in our analysis. Also,
1990—1991 appears in Figure 1 to be more likely
to be the year with the least impact, as we found,
not the third highest which was reported using the
other model. Finally, the two years in which the
models are most divergent are the two inﬂuenza
years dominated by inﬂuenza B, 1990—1991 and
1992—1993, when 86% and 71% of isolates were
type B, respectively (Table 4).4,6 In the past decade
the threat of inﬂuenza B to the elderly has been
less than inﬂuenza A, particularly A(H3N2) because
of the less dramatic changes in the circulating in-
ﬂuenza B viruses and the immunologic memory
retained by many of the elderly due to prior type
B exposure to similar viruses. Thus, we believe
that the new estimates of inﬂuenza-associated P&I
hospitalizations we present using the Thompson
et al. model and the Medicare administrative data
are more accurate than the previously published
estimates.
Even though our estimates of P&I hospitaliza-
tions are lower than those previously published,
the amount reimbursed by Medicare for P&I hos-
pitalizations was very large, up to $494.5 million
per inﬂuenza year. In addition, our estimates of
the cost burden of the disease are conservative.
For example, we did not attempt to include in our
estimates a portion of the costs of hospitalizations
where P&I was one of the secondary diagnoses.
Analyses done by CMS staff for the calendar years
1990—1996 indicate that between 63.3 and 65.4%
of hospitalizations with P&I listed as one of the
diagnoses had P&I in the primary position. Thus,
the total number of P&I cases treated in hospital
was slightly over 50% greater than the number we
attributed to P&I. In addition, we did not include
the payments that are made by Medicare beneﬁcia-
ries, Medigap insurers (Medigap insurance is private
supplemental insurance that is purchased by or for
approximately 85—90% of Medicare beneﬁciaries; it
pays for the Medicare deductibles and co-insurance
charges), or others on their behalf; nor did we in-
clude physician, facility, prescription drugs or other
expenditures associated with inﬂuenza-related
pneumonias treated on an outpatient basis.
Because we did not have the national RSV labo-
ratory surveillance data used by Thompson, et al.1
we were not able to include an RSV term in our
model. While we cannot be certain of the impact
of such an addition on P&I hospitalizations, infor-
mation provided by Thompson, et al.25 indicates
that it should have only a small to minimal ef-
fect on our results. They reported that for their
all-cause mortality models an annual estimate of
51,063 inﬂuenza-associated deaths occurred from
1990—1991 through 1998—1999 if they did not in-
clude the RSV term.25 Including the RSV information
resulted in an estimate of 51,203 deaths (Table 3
of reference 1), a difference of less than 0.03%.
A ﬁnal important reason to monitor and study
the impact of inﬂuenza and other viruses on P&I
hospitalizations and costs in the elderly is to assess
the impact of inﬂuenza vaccination in this popu-
lation. Since 1993 the Medicare program has paid
for inﬂuenza vaccine and its administration for
all beneﬁciaries with Part B coverage. A complete
analysis of the inﬂuenza years for which Medi-
care hospitalization data are currently available
(1986 to 2002) would help determine the impact
of Medicare payment for this beneﬁt. As has been
noted at the recent Options for the Control of In-
ﬂuenza V meeting, P&I mortality does not seem
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to be decreasing26—28 in spite of Medicare reim-
bursement and the immunization of approximately
two-thirds of the elderly U.S. population in each
year since 1997.29,30
The major weakness of our presentation is the
lack of more current information regarding in-
ﬂuenza virus surveillance. We hope that we can
correct that in the future, particularly because the
estimate of the average annual inﬂuenza-related
P&I deaths for 1996—1997 and 1997—1998, 12,278,
is almost double the average number for the years
for which we had inﬂuenza laboratory surveillance
data, 6,703 [reference 1, Table 3]. Also, it would be
good to have RSV laboratory information. However,
as mentioned above, including RSV did not alter the
estimates of inﬂuenza-related all-cause mortality
estimates in the Thompson model,1,25 but this fact
has not been established for P&I hospitalizations.
Further, information regarding the viral cause of
P&I hospitalizations in the elderly throughout the
year would strengthen the association described by
the model.
Unfortunately, the Medicare administrative data
can be used to provide population-based estimates
for P&I hospitalizations only in the elderly. Simon-
sen, et al. estimated that 43% of P&I related hospi-
talizations occurred in persons less than 65 years of
age.24 However, it is the elderly in whom the rates
of death and hospitalization are the greatest. The
mean relative risk for those persons greater than
65 years of age was 6.4 compared with those less
than 65 years of age.24 Finally, until recently, the
elderly was the age group to which most attention
was paid in terms of intervention strategies, and it
will continue to be an age group in which the reduc-
tion of morbidity is a national goal, at least until
2010.31
In conclusion, analysis of P&I-associated hospi-
talizations for a six-year period in the 1990s in-
corporating Medicare administrative data into the
new model proposed by CDC provides estimates of
inﬂuenza-relatedmorbidity that are consistent with
estimates of inﬂuenza-related mortality presented
by CDC. Because of its positive features, we rec-
ommend that the Medicare data be used for future
national projections of the morbidity and ﬁnancial
burden of inﬂuenza in the U.S. elderly population.
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